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Abstract
Background: The oncoproteins of human papillomavirus (HPVs) directly effect cell-cycle control.
We hypothesize that regulatory and cell cycle protein expression might be additionally modified in
the cervix of HIV/HPV co-infected women.
Methods:  We analyzed the expression of Rb, p27, VEGF and Elf-1 transcriptor factor by
immunohistochemistry in 163 paraffin-embeded cervical samples using Tissue Micro-Array (TMA)
and correlated this to HIV-1 and HPV infection.
Results: HIV/HPV co-infection was associated with a significant increase in expression (p < 0.001)
of VEGF and p27 in both low and high grade CIN when compared to the cervices of women
infected by HPV alone. Decreased Rb expression was evident with increased CIN grade in the
cervices of women infected with HPV alone (p = 0.003 average of cells/mm2 in CIN I: 17.9, CIN II/
III: 4.8, and tumor 3.9). Rb expression increased 3-fold for both low and high grade CIN with HPV/
HIV-1 co-infection compared to HPV infection alone but did not reach statistical significance. There
was a significant increase in Elf-1 expression in HPV+/HIV- women with CIN II/III and tumor
(average of cells/mm2 in CIN I: 63.8; CIN II/III: 115.7 and tumor: 112.0, p = 0.005), in comparison
to controls.
Conclusion: Co-infection of HPV and HIV leads to significant increase in the VEGF and p27
expression when compared to HPV+/HIV-negative infection that could facilitate viral persistence
and invasive tumor development.
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Background
Human papillomavirus (HPVs) are DNA viruses that pro-
duce hyperproliferative lesions in epithelial tissues. High-
risk HPV genital infection, in particular HPV types 16 and
18, is associated with the development of genital cancer,
while the low-risk HPVs induce benign genital warts. The
oncogenic potential of HPV is, in part, mediated by the E6
and E7 proteins, which are known to bind and inactivate
the p53 and retinoblastoma protein (pRb) respectively.
Rb is one of the most investigated tumor suppressor genes
and its dysregulation has been associated with neoplastic
growth in a variety of tumors [1]. The ability of HPV onco-
proteins to disrupt growth regulatory proteins may have
effects on the cyclin-dependent kinase (CDK) inhibitors
linked to the G1- and G2- checkpoints. A group of CDK
inhibitors, which includes p21, p27 and p57, inhibits the
cyclin/cdk2, cdk4 complexes and causes G1 arrest. These
proteins are rarely mutated in human tumors and their
expression levels is of prognostic significance in a wide
spectrum of tumors [2]. P27 may be inactivated upon
binding to DNA tumor virus oncoprotein, such as HPV 16
E7, can be deregulated early in carcinogenesis and may
precede tumor invasion. Other HPV proteins act indirectly
by altering the function of cellular factors. The loss of cell-
cycle control leads to increased proliferation that can be
detected by the increased number of cells in the cycle
expressing specific markers [3].
Among the proteins and factors involved in cellular
growth, VEGF (vascular endothelial growth factor) is a
potent angiogenic factor that operates as an angiogenesis
tumor mediator [4]. The role of VEGF in cervical carcino-
genesis has been studied and it is established that the
VEGF expression has been related to microvascular den-
sity (MVD) in cervical intraepithelial neoplasia (CIN) and
invasive carcinomas, suggesting that VEGF is an early
marker of cervical carcinogenesis, with linearly increasing
expression starting from low grade CIN [4]. Another factor
is eukaryotic translation initiation factors (Ets), which
includes Elf, a lymphoid-specific member of this family,
known to regulate inducible gene expression during T cell
activation which includes increased angiogenesis. An
over-expression of these factors can lead to neoplastic cel-
lular change and tumor. Recent report supported a role of
Elf-1 in the development of tumor angiogenesis and
showed that targeting of Elf-1 in melanoma tumors
resulted in decreased angiogenesis [5].
There is still relatively little data on biomarkers that may
relate to increased risk of progression of CIN to cervical
cancer [6,7] however, there is evidence that a few markers
can be used as more specific risk assessment tools [8].
HIV/HPV co-infection is associated with a marked
increase risk in progression of CIN to cervical cancer [9].
Although the reasons for this observation are not well
understood, cytokine profile alterations, including
RANTES, have been described in co-infected patients [10].
Data suggests that HPV infection of the cervix might influ-
ence HIV pathogenesis by inducing both immune and
inflammatory related protein production that enhances
HIV expression [11].
Recent insights into molecular pathogenesis have demon-
strated that HIV-1 proteins can directly lead to cancer
growth by interfering with cellular functions. Also, HIV-1
proteins such as Tat can interact with the RB2/p130 tumor
suppressor gene product and induce increased cell prolif-
eration [12]. However the mechanisms whereby HIV-1
subverts cell-cycle controls in the infected cervix have
been unclear. Despite the fact that some reports have
shown a role of VEGF, Rb, p27 in the HPV cervical CIN
progression, little is known about the involvement and
expression of these proteins in the HIV/HPV co-infection.
We investigated the hypothesis that HIV would modify
the expression of regulatory and cell-cycle proteins in the
cervix of HIV/HPV co-infected women. By using tissue
micro-array (TMA) and immunohistochemistry to pRb,
p27, VEGF and ELF-1, different CIN grades from HIV/HPV
co-infected women were analyzed and compared to HPV/
HIV-negative patients.
To our knowledge this is the first study to analyze the
expression and protein alterations in different CIN grades
in HIV and HPV co-infection correlating these protein
alterations with histopathological and clinical features to
evaluate putative prognostic marker potential.
Methods
Patients and tissue Samples
One hundred and sixty three fixed formalin, paraffin
embedded samples with a histopathological diagnosis of
CIN, cervicitis or cancer in cervical loop excisions and
cone specimens were selected from the archives of the
Department of Pathology of the Fernandes Figueira Insti-
tute (IFF), Fiocruz, Rio de Janeiro, Brazil. The IFF is a hos-
pital that receives patients showing abnormal pap smears
from Public Health Units of the State of Rio de Janeiro.
Ninety-two cervical samples came from HPV positive
women who were negative for HIV-1 and 37 were from
HPV/HIV co-infected women. Thirty-four tissues diag-
nosed as nonspecific chronic cervicitis in women with no
evidence of HPV or HIV-1 infection were used as controls.
Clinical data such as HIV-1 status, viral load, CD4/CD8
cell counts, age, other associated STDs and the use of anti-
retroviral treatments (ARV/HAART) were obtained from
patient files. The study was approved by the Ethical Com-BMC Cancer 2008, 8:289 http://www.biomedcentral.com/1471-2407/8/289
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mittees Review Board of Evandro Chagas Clinical
Research Institute and IFF, both from Fiocruz.
Tissue Micro-Array (TMA) block construction
The TMA blocks were constructed as described by Pires et
al, 2006 [13]. Briefly, all hematoxylin-eosin (HE) slides
were re-examined by an experienced pathologist and two
morphologic representative fields of higher CIN level
were chosen and encircled with a marker pen. Two cores
from each case were punched out from the donor blocks.
Starting from the selected regions, the corresponding H&E
slides were overlaid with a custom-built 16 gauge Becton-
Dickinson PrecisionGlide® hypodermic needle (1,1 mm2
area). Afterwards cores were attached by double-side
adhesive tape on a computer-generated paper grid afford-
ing alignment on the block mould, which was then filled
with liquid paraffin. Three μm thick sections were
obtained from an American Optical standard rotator
microtome. Each block provided 40–50 slides, containing
variable tissue core lengths. Only samples showing the
original lesion were considered. The design of each block
was detailed in a TMA map (spreadsheet), indicating the
position and identification of each core. Normal tissue
(placenta) and position-specific blank cores were adopted
for orientation during microscopy analysis. A total of
three TMA blocks were constructed, one with HPV/HIV
co-infected cervical biopsies, another with controls
together with CIN I and the third with CIN II/II, Ca and
tumor.
HPV Testing
The presence of HPV DNA was determined through a pre-
viously published in situ hybridization assay [14,15]. In
brief, the probe cocktails can detect either the low risk
HPV types (HPVs 6,11,42,43,44) or the high risk HPV
types (HPVs 16,18,31,33,35,45,51,52,56,58,68) (Enzo
Life Sciences, Farmingdale, NY, USA). The probe-target
complex is detected due to the action of alkaline phos-
phatase on the chromogen nitroblue tetrazolium and bro-
mochloroindolyl phosphate(NBT/BCIP) yielding a dark
blue color with a pink counterstain for the HPV negative
cells due to nuclear fast red.
Immunohistochemistry (IHC)
IHC reactions were performed on TMA silane-coated
slides (Sigma, St. Louis, MO, USA), dried overnight at
37°C and then dewaxed, rehydrated and treated in hydro-
gen peroxide 3% in methanol for 10 min to eliminate
endogenous peroxidase activity. The LSAB system HRP
(Dakocytomation, Carpinteria, CA, USA) method was
adopted for immunolabelling. Tissue sections were
sequentially incubated for 1 hour at room temperature
with the specific antibodies (dilutions): anti-VEGF mono-
clonal antibody (1/400), anti-Elf-1 polyclonal antibody
(1/300), anti-Rb monoclonal antibody (1/25) and anti-
p27Kp1 monoclonal antibody (1/20) (DakoCytomation,
CA USA). A secondary biotinylated multilink antibody
was incubated with the streptavidin-HRP conjugate for 30
min and the signal visualized with 3.3 diaminobenzidine
(Sigma Chemical Co., St. Lois, MO, USA) and 85 μl of
hydrogen peroxide 0.3%. Hematoxylin was the counter-
stain and the omission of the primary antibody, which
eliminated the signal in each case, served as an additional
control.
Assessment of IHC slides and cell counting
The microscopic analysis of the slides was independently
performed by two investigators. Positive stained cells were
counted in the epithelium and stroma at 400× magnifica-
tion. The total average area counted in the epithelium/
stroma was: controls- 882/766 (SD 82,02) cells/mm2;
CIN I – 867/642 (SD 159,09) cells/mm2; CIN II/III – 813/
538 (SD 194,45) cells/mm2; carcinoma – 1.135/589 (SD
386,08) cells/mm2respectively. Digitalized photographs
were taken with a Nikon COOLPIX Camera DP12, and
the images stored in a computer-based software (Image-
Pro 4.5) for documentation.
Statistical Analysis
Data analysis was carried out with the SAS System (SAS
version 9.1, Cary, North Carolina, USA). Preliminary
analyses verified that data did not follow a normal distri-
bution, so we used non-parametric tests for comparisons.
Mann-Whitney U, Kruskal Wallis and Dunn's tests were
applied to compare means of positive cells in the epithe-
lium and stroma which was then compared to peripheral
CD4+T cells (< 200 and ≥ 200 cells/mm3), CIN grade, and
presence/absence of HPV and/or HIV-1 infection. Differ-
ences were considered significant at p < 0.05.
Results
Histopathological data
HPV+/HIV-negative cervices (n = 92) were classified as
low grade (CIN I; n = 33) or high grade/CIN (CIN II/III; n
= 47). Twelve additional cases of invasive cancer, consist-
ing of 3 cases of adenocarcinoma and 9 of squamous cell
carcinoma (SCC) were included in the study. HPV+/HIV+
co-infected cervices (n = 37) were classified as low grade
CIN (CIN I; n = 14) and high grade CIN (CIN II/III; n =
23).
Immunohistochemical data: Overview
The expression of VEGF, Rb, Elf-1 and p27 in the epithe-
lium of the cervical biopsies that were co-infected with
HPV+/HIV+ was compared to the cervices infected by HPV
alone. The results are summarized in Table 1 and Graphic
1 [see Additional file 1]. There was a statistically signifi-
cant increase (p = 0.001) in the number of cells expressing
VEGF and p27 in HIV+/HPV+ co-infection as compared to
the HPV+/HIV-. Note that this increase was evident forBMC Cancer 2008, 8:289 http://www.biomedcentral.com/1471-2407/8/289
Page 4 of 10
(page number not for citation purposes)
both CIN I and CIN II/III. Table 2 provides a compilation
of the comparisons of the number of epithelial cells
expressing VEGF, p27, Rb, and Elf-1 in the cervicitis con-
trols, CIN I, CIN II/III, and invasive carcinoma in women
with HPV infection alone.
Elf-1 expression
Elf-1 was evidenced in the cervical squamous epithelium,
exhibiting a strong nuclear staining (Fig. 1A and 1B), par-
ticularly in the areas of CIN II/III. In non-neoplastic areas
or without evidence of dysplasia, Elf-1 staining was scat-
tered in the basal cell layer (Fig. 1C). In comparison, Elf-1
was not evident in the endocervix (Fig. 1D). The squa-
mous cell cancer cases also showed a strong nuclear-based
signal, whereas the adenocarcinoma cases displayed
multifocal staining (Fig. 1E and 1F). HPV+/HIV- infection
showed statistical significant difference both in the epi-
thelium (p = 0.005) and stroma (p = 0.009, data not
shown). However, the Dunn's test failed to show differ-
ences between the controls and CIN I, CIN II/III and
Table 1: Comparison between HPV and HPV/HIV co-infection with the different markers analyzed
NIC I NICII/III
Marker HPV/HIV- HPV/HIV+ P-value* HPV/HIV- HPV/HIV+ P-value*
VEGF-epit
Mean (SD) 74.9 (64.3) 161 (63.0) 0.001 89.6 (52.7) 169.5 (56.6) < 0.001
Median (IQR) 70 (12 – 102) 161 (104 – 220) 82 (47 – 127) 162 (125–220)
(n) (32) (12) (41) (22)
P27 epit
Mean (SD) 3.35 (20.5) 24.5 (34.4) < 0.001 4.85 (15.2) 10.21 (12.0) 0.001
Median (IQR) 0 (0 – 0) 10 (5 – 33) 0 (0 – 3) 8 (0–16)
(n) (31) (13) (32) (22)
Rb epit
Mean (SD) 11.5 (17.8) 33.6 (52.6) 0.141 3.41 (11.7) 11.5 (25.5) 0.110
Median (IQR) 0 (0 – 24) 19 (0 43) 0 (0 – 0) 0 (0–6)
(n) (29) (13) (41) (21)
Elf-1 epit
Mean (SD) 48.6 (60.4) 93.1 (77.8) 0.191 133.5 (96.4) 98.5 (81.4) 0.509
Median (IQR) 20 (2 – 75) 69 (35–177) 99 (50 – 216) 69 (43–161)
(n) (27) (14) (35) (21)
*Mann-Whitney U test – The mean difference is significant at p < 0.05. IQR: Interquartile Range
Table 2: Protein expression in the epithelium (cells/mm2) of different studied markers in the uterine cervix from HPV+/HIV-negative 
infection
Marker VEGF P27 Rb Elf-1
Chronic cervicitis
Mean (SD) 36.73 (52.37) 0.19 (0.73) 12.5 (17.6) 76.26 (59.27)
Median (IQR) 0 (0 – 51.5) 0 (0–0) 0 (0 – 20) 65 (39 – 95)
(n) n = 33 n = 32 n = 27 n = 27
CIN I
Mean (SD) 102.5 (73.8) 8.25 (20.5) 17.9 (31.6) 63.8 (70.4)
Median (IQR) 74 (17.5 – 105.75) 0 (0 – 0) 0 (0 – 25.50) 20 (4 – 78)
**
(n) n = 32 n = 31 n = 29 n = 27
CIN II/III
Mean (SD) 127.7 (85.9) 9.26 (23.1) 4.8 (16.4) 115.7 (88.3)
Median (IQR) 77 (47 – 136) 0 (0 – 2.75) 0 (0 – 0) 99 (40 – 203)
** **
(n) n = 41 n = 32 = 41 n = 35
Tumor
Mean (SD) 163.1 (187.36) 3.0 (3.0) 3.9 (12.3) 112 (87.6)
Median (IQR) 96 (43 – 248.5) 3 (0 – 6) 0 (0–.0) 101 (35. 5–166)
**
(n) n = 9 n = 9 n = 10 n = 9
p-value* < 0.001 0.047 0.003 0.005
Kruskal Wallis test – The mean difference is significant at p < 0.05. ** Dunn's test (α 0.05). IQR: Interquartile RangeBMC Cancer 2008, 8:289 http://www.biomedcentral.com/1471-2407/8/289
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Expression of Elf-1 in HIV+/HPV+ co-infected cervical tissues Figure 1
Expression of Elf-1 in HIV+/HPV+ co-infected cervical tissues. Panel A and B shows Elf-1 expression in ectocervical 
epithelium negative for CIN and CIN I respectively. Note that the signal is seen mainly in the basal layer of the epithelium 
(100× and 200×, respectively). Panel C – shows that the signal was evident only in the dysplastic cells in the CIN II lesion 
(100×). Panel D demonstrates that the Elf-1 signal tends to be more prominent in the squamous component as compared to 
the negative endocervical tissue (200×). Panel E – The signal in the squamous cell carcinoma tissues also localized to the neo-
plastic squamous cells (100×). However, neoplastic glandular cells demonstrated a multifocal signal as compared to the nega-
tive unremarkable endocervical tissue (panel F, 400×).BMC Cancer 2008, 8:289 http://www.biomedcentral.com/1471-2407/8/289
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tumor. The epithelium of CIN II/III and tumor exhibited
higher expression (115.7 and 112 cells/mm2 respectively)
compared to control and CIN I (76.26 and 63.8 cells/mm2
respectively).
Although no significant differences appeared, the HPV+/
HIV+ co-infected cervices, denoted a direct relation
between increasing grade of the lesion and the intensity of
staining in the epithelium as observed in CIN I (87.3 cells/
mm2) and CIN II/III (104 cells/mm2). All invasive cancers
in this study demonstrated high levels of proliferating cell
nuclear staining indicative of cell proliferation.
VEGF expression
VEGF was observed in the endothelial cells of the small
vessels as well as in the cytoplasm of the squamous cells,
particularly in the upper and intermediate layers (Fig. 2A–
2C). The intensity of the signal of the positive squamous
cells was stronger in the CIN II/III lesions and carcinomas
compared to the normal cervical tissue and CIN I (Fig.
2D). As already indicated, there was also a marked and
significant increase in the number of positive cells with
increasing CIN grade of the lesion in the HPV+/HIV-neg-
ative compared to controls, (p = < 0.001) by both Kruskal
Wallis's and Dunn's test. HPV+/HIV+ co-infection cervices
was markedly expressed in both CIN I and CIN II/III,
however it not shown statistical significance.
Rb expression
The Rb signal was evidenced by nuclear staining mainly in
the basal layer of the epithelium (Fig. 2E). As evident from
Table 1, the expression of Rb positive epithelial cells
increased about 3-times in both CIN I and CIN II/III
lesions when comparing the HPV+/HIV+ co-infected
women to those infected by HPV alone. Interestingly,
increasing grades of CIN were associated with decreased
Rb epithelium expression in HPV+/HIV-negative cervices
(average of cells/mm2 in CIN I: 17.9, CIN II/III: 4.8, and
tumor 3.9, p = 0.003) when compared to the cervicitis
control (Table 2). This difference was significant using the
Dunn's test in the category of CIN II/III compared to CIN
I. Tumor cervices have shown a decreased expression,
however no statistical difference was found probably
caused by the reduced number of samples analyzed.
Separated analysis of HPV+/HIV+ co-infected cervices in
the category of CIN II/III versus CIN I demonstrated sig-
nificant difference (average of cells/mm2 in CIN I: 28.9,
CIN II/III: 10, p = 0.042), decreasing according to the CIN
progression. Rare positive cells were seen in the stroma (p
= 0.02, data not shown).
p27 expression
p27 expression was evidenced as a nuclear signal in the
superficial layer of the epithelium, mainly in the koilo-
cytes (Fig. 2F). The stromal immunoreactive cells were
inflammatory cells, with fewer numbers of positive cells
evident in the stroma of squamous cell carcinomas. As
discussed, p27 expression in epithelial cells was markedly
increased in both CIN I and CIN II/III when comparing
the HPV/HIV co-infected women to HPV infection alone
(Table 1). When analyzing just HPV infected women com-
pared to controls (Table 2), it was evident that p27 expres-
sion was markedly increased in both CIN I and CIN II/III
(8.25 and 9.26 cells/mm2) and decreased in tumor (3.0
cells/mm2) cervices compared to the non-infected con-
trols (0.19 cells/mm2).
Clinical data of HIV/HPV co-infected women
Peripheral CD4 findings
Peripheral CD4 counts in HIV/HPV co-infected women
did not demonstrate statistical differences (p = 0.81)
when comparing low to high grade CIN lesions (Table 3).
Table 3 summarizes the clinical data from HIV/HPV co-
infected women. We then compared expression of VEGF,
p27, Elf-1, and Rb relative to antiretroviral therapy (ARV).
These comparisons showed one significant difference.
Specifically, the Elf-1 transcriptor factor was less expressed
in the epithelium group of patients not submitted to ARV
treatment compared with those undergoing mono, dual
and HAART (p < 0.005), (data not shown).
HPV detection and TMA
Three different methods were employed to confirm the
presence of HPV in the cervical samples. First, the hema-
toxylin and eosin stained slides were reviewed and all cer-
vical biopsies with histologic findings of CIN were
considered HPV positive given the large amount of data
indicating that such lesions invariably contain the virus
[12]. Second, HPV DNA was detected by the Hybrid cap-
ture HPV assay (Digene Diagnostic, USA) in the liquid
based Pap smears in 12 of 37 HIV+/HPV+ co-infected
women with CIN. Finally, HPV DNA in situ hybridization
was conducted to document the presence of the virus in
the TMA (Fig. 2G), and 67 were HPV DNA positive.
This comparative study underscored the value of the tissue
Micro-Array (TMA) for possible putative prognostic mark-
ers, as it made possible the comparison of a large number
of different CIN grade samples (Fig. 2H).
Discussion
Our study confirmed the hypothesis that there is signifi-
cantly altered expression of regulatory and cell cycle pro-
teins in the cervix due to HIV-1 infection occurring in the
context of a co-existing HPV infection. Specifically, the
epithelial cells expressing VEGF and p27 was significantly
increased with HIV+/HPV+ co infection compared to HPV
infection alone for both CIN I and CIN II/III lesions. This
effect by HIV-1 was additive to the HPV infection, as theBMC Cancer 2008, 8:289 http://www.biomedcentral.com/1471-2407/8/289
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Expression of VEGF, Rb, and p27 in cervical tissues Figure 2
Expression of VEGF, Rb, and p27 in cervical tissues. Panel A shows VEGF expression in the negative control cervical tis-
sue that was evident mostly in the basal layer of the epithelium (100×). VEGF expression was seen in the small vessels as well 
as in the cytoplasm of the dysplastic epithelium cells, particularly in the upper and intermediate layers in CIN I (panel B) and in 
CIN II/III (panel C),(100×). Panel D shows a squamous cell carcinoma showing a diffuse cytoplasmic positivity for VEGF in the 
neoplastic cells (100×). In panel E the strong nuclear expression of Rb is evident in CIN I, localizing mainly to the basal layer of 
the epithelium (200×). Panel F shows p27 nuclear staining in the superficial layer of the epithelium, mainly in the koilocytes of a 
CIN I lesion (200×). Panel G shows HPV DNA detection by in situ hybridization in the CIN II/III HPV TMA case (400×). Panel 
H shows a low magnification view of several Tissue Micro-Array cervical samples used in the present study (20×).BMC Cancer 2008, 8:289 http://www.biomedcentral.com/1471-2407/8/289
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latter per se was also associated with statistically increased
expression of VEGF and p27 in CIN I-III and invasive can-
cers. Some explanations could be raised, including immu-
nosuppression and the persistent HPV infection
frequently seen in the HIV-1 infected patients. However,
the mechanisms and the pathway by which HIV-1 can
trigger these proteins require further molecular studies.
The modulation of p27, VEGF, and, perhaps, Rb expres-
sion may provide some insights into why HIV-1 infection
of the cervix appears to be associated with an increased
risk of cervical cancer in women co-infected by HPV. HIV-
1 proteins can directly promote cancer growth by interfer-
ing with cellular functions. For example, the HIV tat pro-
tein has been shown to physically interact with the RB2/
p130 tumor suppressor gene product [12] which may pro-
mote the effect of HPV oncoproteins. The effect of the
HPV oncoproteins E6 and E7 may, in turn, be related to
viral load [16]. On the other hand, the interactions
between hr-HPV oncoproteins and molecules involved in
cell cycle regulation are clearly related to the development
of cervical cancer. Certainly other co-factors such as the
HPV viral load may be predictive of the future risk of
developing high-grade dysplasia or carcinoma, even in
patients with negative Pap smears [16]. In HIV-infected
women, HPV viral load is consistently high, which may
explain in part the higher probability of high-grade dys-
plasia development [17]. In the present study we could
not assay the local HPV viral load, but 57,5% of the HIV/
HPV co-infected women exhibited high grade CIN. Per-
sistent infection is the most important risk factor for initi-
ating malignant transformation in the cervical
epithelium, and a recent study reported that the time-
frame from initial infection to pre-invasive and invasive
disease appears to be at least 10–15 years [1].
Angiogenesis is important factor in the progression of CIN
to invasive cancer and can be induced by many factors,
including VEGF. In the present study we found that there
was an increase in VEGF expression in the HPV only
infected cervices, reaching the highest point in the inva-
sive cancer cases, which is consistent with other report [4]
that described a linear increasing from low grade CIN to
high grade CIN and cancer lesions, suggesting that VEGF
is a diagnostic marker for early stages of cervical carcino-
genesis. However, in control cervices, we did find a low
immunoreactivity both in the epithelium and stroma,
perhaps explained by the fact that the vast majority of cer-
vical tissues, even if taken from hysterectomy specimens
where there is no suggestion of HPV infection, will exhibit
inflammatory infiltrates in the cervix, that is, chronic cer-
vicitis. In the HPV+/HIV+ co-infected cervices VEGF was
highly expressed in both CIN I and CIN II/III, and showed
no statistical difference.
The Elf-1 factor is a transcription factor that regulates a
number of inducible lymphoid-specific genes and also in
the development of tumor angiogenesis [5]. Elf-1 expres-
sion was statistically equivalent in the HPV alone and
HPV/HIV-1 co-infection, suggesting that HIV-1 per se was
not modulating its expression. Elf-1 expression did
increase in CIN II/III and carcinoma lesions compared to
Table 3: Clinical and Histopathological data from HIV/HPV co-infected woman
Histopathology CIN I n = 14 CIN II/III/Ca n = 23 All N = 37
Log V. load
Mean (SD) 2.73 (1.42) 1.98 (1.35) 2.29 (1.40)
Median(IQR*) 1.90 (1.89–4.2) 1.84 (0.67–3.21) 1.89 (0.70–3.68)
Not available 5 (35.7%) 11 (47.8%) 15 (40.5%)
CD4
Mean(SD) 336.3 (275.8) 269.1 (99.3) 300.7 (198.5)
Median(IQR*) 217.5 (107–571) 249 (220–344) 249 (150–383)
Not available 6 (42.8%) 14 (60.8%) 20 (54.0%)
CD8
Mean(SD) 953.6 (338.8) 685.8 (214.5) 850.6 (317.3)
Median(IQR*) 980(743–1241) 619(509–896) 958(564–1061)
Not available 6(42.8%) 18(78.2) 24(64.8%)
Age
Mean(SD) 37.3 (7.12) 35 (7.6) 36.0 (7.4)
Median(IQR*) 38(33–42) 35(30–44) 36.5(31–42.7)
Not available 1(7%) 0(0%) 1(2.7%)
ARV
HAART 3(21.4%) 7(30.4%) 10(27%)
Mono/Dual 2(14.3%) 4 (17.4%) 6(16.2%)
No use 8(57.1%) 11(47.8%) 19(51.4%)
Not available 1(7.1%) 1(4.3%) 2(5.4%)
*IQR: Interquartile RangeBMC Cancer 2008, 8:289 http://www.biomedcentral.com/1471-2407/8/289
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the negative controls in HPV alone infected cervices and
did reach statistical significance, suggesting that molecu-
lar events in the more progressed HPV infected cervices
was increasing Elf-1 expression. Interestingly, Elf-1 was
less expressed in patients without ARV treatment com-
pared with those undergoing mono, dual or HAART (p <
0.005), possibly justified by the fact that some cellular
transcription factors can bind to the HIV-1 5' long termi-
nal repeat (LTR). However, the contribution of these fac-
tors to human immunodeficiency virus type 1 replication
in infected individuals remains obscure [18].
Many tumor suppressor genes, most of them involved in
the cell cycle, have been described, the functional loss of
these suppressor gene pathways probably being the basis
for cervical carcinogenesis. P27, an important cell cycle
inhibitor protein, is involved in the growth and differen-
tiation of the normal squamous epithelia of the uterine
cervix, and controversial data have been described in the
literature. Some authors have found that low levels of p27
are associated with poor prognosis and suggested that
decreased p27 protein might contribute to the altered
kinetics of the dysplastic and neoplastic cervical epithe-
lium [19,20], whereas others have suggested that an
increased and/or aberrant function of p27 expression may
occur in invasive squamous cell carcinoma of the cervix
[21]. Our data showed a marked increase in p27 infection
by HPV alone in all CIN grades compared to controls, and
decreased in tumor compared to any other group of CIN.
One possibility to explain this increase is the blocking of
p27 activity by the HPV oncogene E7 which binds p27 via
its C terminus. However, the mechanisms by which the
HIV would modify this activity is unknown. It is impor-
tant to recall that cell cycle control is a multifactorial sys-
tem and, for example, decreased Rb expression may
increase cyclin E and cdk2 which, in turn, can overcome
the tumor suppressive effect of increased p27 [22]. In this
connection, our data show that there was a 3-fold increase
in Rb expression with HIV-1 co-infection versus HPV
infection alone, but this did not reach statistical signifi-
cance, there may well be a stimulatory effect on Rb pro-
duction due to HIV-1 co-infection in this context. This
possibility will require additional studies. Nonetheless,
since Rb expression decreased in CIN II/III and carcinoma
in HPV only infected cervices compared to the negative
controls, corroborating the previously published data
[23,24]. Interestingly, HIV-1 co-infection appeared to res-
cue Rb expression which may, in turn, potentiate the
increased expression of p27 [25]. However, this interac-
tion by itself may not be sufficient for neoplastic transfor-
mation and other cofactors may be required.
Nevertheless, it is likely that the deregulation of cellular
genes and function by Tat can also cause abnormalities
that may contribute to AIDS pathogenesis and to the
development of AIDS-associated disorders [12].
This comparative study adopting Tissue Micro-Array for
possible putative prognostic markers, made possible the
comparison of a large number of different CIN grade sam-
ples, and demonstrated to be a useful research tool, pri-
marily for immunohistochemistry procedures, in spite of
some limitations. First, we could not assay high risk-HPV
sub-typing in all samples, which prevented comparison
between Hr-HPV types with the expression markers in the
different CIN grades. Second, we cannot accurately deter-
mine the HPV type in these relatively small cores. Third,
we decided to use nonspecific cervicitis as controls, as
most transformation zone biopsies, even from women
with no evidence of HPV or HIV-1 infection, show non-
specific cervicitis. Despite the limitations, we were able to
document statistically significant changes due to HIV-1
co-infection in HPV infected cervices.
The neoplastic process of the uterine cervix occurs in the
epithelium. In the present study we analyzed the expres-
sion of different markers both in the epithelium and stro-
mal tissue, however we focused our analysis in the
epithelium. Although VEGF demonstrated significant dif-
ferences (p < 0.001) in low grade CIN compared to con-
trol in the HPV+/HIV-negative patients, this marker was
also increased in high grade CIN, suggesting that it is not
a good marker for CIN progression. Increasing grades of
CIN were associated with decreased Rb expression cervi-
ces, however further studies with more infected cervices
should be done in order to confirm these observations.
Additionally, we suggest that many immune markers that
have been studied as CIN progressors should also be eval-
uated in HIV/HPV co-infection, since this group of
patients may have different clinical and immune out-
comes.
Conclusion
In conclusion, this study demonstrated a significant
altered expression of regulatory and cell cycle proteins
such as VEGF and p27 in cervical samples from HPV+/
HIV+ co-infected compared to HPV+/HIV-negative
women, suggesting that HIV-1 virus may be triggering
these proteins which in turn could facilitate viral persist-
ence and progression to an invasive tumor.
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